StockData
Anbio Biotechnology logo

Anbio Biotechnology (NNNN) stock

NNNNNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 7, 2026Score 11/30
$3.65−0.23 (-5.93%)

Close on Nov 17, 2026Market cap $525.20MP/E 24.8Yield –

Anbio Biotechnology total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

No total debt figures for Anbio Biotechnology

Anbio Biotechnology has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Anbio Biotechnology figures

See a number that looks wrong?